Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444957) titled 'Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease' on Feb. 24.
Study Type: Observational
Primary Sponsor: Fundación Interhospitalaria para la Investigación Cardiovascular FIC
Condition:
Coronary Arterial Disease (CAD)
NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
Stable Angina, Unstable Angina, NSTEMI
Drug Coated Balloon
ST-Elevation Myocardial Infarction
Silent Ischemia
Recruitment Status: Recruiting
Date of First Enrollment: January 5, 2026
Target Sample Size: 1118
Countries of Recruitment:
Spain
To know more, visit http...